Canine Tick-Borne Diseases: Lyme Disease, Ehrlichiosis, Anaplasmosis, and Babesiosis

Introduction

Canine tick-borne diseases represent a significant and growing global health concern for domestic dogs. These diseases are caused by a diverse array of pathogens, including bacteria, protozoa, and viruses, which are transmitted through the feeding activity of hematophagous ticks [1, 2]. The clinical presentation of these infections is often nonspecific and overlapping, presenting a substantial diagnostic challenge for veterinary practitioners [3]. The term "dog tick transmitted diseases" encompasses a spectrum of conditions that vary in geographic distribution, vector specificity, and pathogenic mechanism [4, 5]. This article provides a detailed, publication-grade review of four major canine tick-borne diseases: Lyme disease (borreliosis), ehrlichiosis, anaplasmosis, and babesiosis. The focus is on the biological, chemical, and physical mechanisms of host-pathogen interactions, diagnostic assay physics, and evidence-based clinical management.

Etiology and Pathogen Biology

Lyme Disease (Borreliosis)

Lyme disease in dogs is caused by the spirochete bacterium Borrelia burgdorferi sensu lato, a member of the family Spirochaetaceae [6, 7]. The pathogen is an obligate parasite that resides in the midgut of ixodid ticks, primarily those of the Ixodes ricinus complex [7]. Transmission to the canine host occurs during tick feeding, when the spirochetes migrate from the tick midgut to the salivary glands and are inoculated into the dermis [8]. The bacteria possess a unique outer surface protein (Osp) profile that facilitates immune evasion and tissue colonization [8]. The primary reservoir hosts for B. burgdorferi are small rodents and birds, with dogs serving as incidental hosts [7].

Ehrlichiosis

Canine monocytic ehrlichiosis is caused by Ehrlichia canis, a Gram-negative, obligate intracellular bacterium belonging to the family Anaplasmataceae [4, 9]. The pathogen is transmitted primarily by the brown dog tick, Rhipicephalus sanguineus sensu lato [9, 10]. E. canis infects circulating monocytes and macrophages, where it replicates within membrane-bound vacuoles called morulae [8]. The bacterium has a tropism for cells of the mononuclear phagocyte system, leading to systemic dissemination and immune-mediated pathology [2, 9]. Other Ehrlichia species, such as Ehrlichia chaffeensis, have been reported in dogs but are less common [28].

Anaplasmosis

Canine anaplasmosis is caused by two primary species: Anaplasma phagocytophilum (formerly Ehrlichia equi) and Anaplasma platys [11, 9]. A. phagocytophilum is transmitted by Ixodes spp. ticks and infects granulocytes, particularly neutrophils, causing granulocytic anaplasmosis [11, 12]. A. platys is transmitted by R. sanguineus and infects platelets, leading to infectious cyclic thrombocytopenia [4, 9]. Both species are obligate intracellular bacteria that replicate within host cell vacuoles [8].

Babesiosis

Canine babesiosis is caused by protozoan parasites of the genus Babesia, which are intraerythrocytic apicomplexans [4, 3]. The major species affecting dogs include Babesia canis (a large piroplasm) and Babesia gibsoni and Babesia vogeli (small piroplasms) [4, 13, 14]. Transmission occurs via the bite of infected ticks, primarily R. sanguineus and Dermacentor spp. [15, 10]. The parasite undergoes a complex life cycle involving sexual reproduction in the tick vector and asexual multiplication (merogony) within canine erythrocytes [16]. The rupture of infected red blood cells leads to hemolytic anemia and hemoglobinuria [15, 14].

Epidemiology and Geographic Distribution

The epidemiology of canine tick-borne diseases is closely linked to the distribution of competent tick vectors and environmental factors such as climate and habitat [17, 7]. Global warming and increased travel with companion animals have facilitated the expansion of tick populations and the emergence of these pathogens in non-endemic regions [17, 12].

Global Prevalence

Studies from diverse geographic regions reveal high prevalence rates of tick-borne pathogens in dog populations. In India, a survey using PCR detected an overall infection rate of 49.7% in dogs, with Hepatozoon canis (30.0%), E. canis (20.6%), and A. platys (6.5%) being the most common [4]. In Thailand, E. canis was the most frequently detected pathogen in both dogs and R. sanguineus ticks [29]. A study in Romania found that 45% of sick dogs were infected with protozoan parasites, predominantly B. canis [3]. In Hong Kong, Babesia gibsoni was detected in 27.1% of dogs suspected of tick-borne infection [14]. In the USA, seroprevalence studies in hunting dogs have demonstrated significant regional variation in exposure to Anaplasma spp., Babesia spp., Ehrlichia spp., and B. burgdorferi [32].

Co-infections

Co-infections with multiple tick-borne pathogens are common and can complicate diagnosis and clinical management [4, 3, 18]. In a study from Lithuania, double, triple, or even quadruple co-infections with A. phagocytophilum, Borrelia spp., Babesia spp., and Dirofilaria spp. were detected in dogs [12]. In India, concurrent infections occurred in 39% of PCR-positive cases [4]. The presence of one pathogen should raise clinical suspicion for others, as co-infections may exacerbate disease severity [3, 18].

Clinical Signs and Pathophysiology

The clinical manifestations of canine tick-borne diseases are highly variable, ranging from subclinical infection to severe, life-threatening illness [8, 19]. The pathophysiology is driven by direct cellular damage, immune-mediated destruction, and systemic inflammation [2, 15].

Lyme Disease

Many dogs infected with B. burgdorferi remain asymptomatic [8]. When clinical signs do occur, they typically include acute-onset lameness due to polyarthritis, fever, lethargy, and lymphadenopathy [8]. The lameness may be shifting and is often accompanied by joint effusion [8]. Renal involvement, specifically Lyme nephritis, is a rare but severe complication characterized by protein-losing nephropathy and renal failure [8].

Ehrlichiosis

Canine ehrlichiosis progresses through three phases: acute, subclinical, and chronic [8]. The acute phase, occurring 1-3 weeks post-infection, is characterized by fever, depression, anorexia, lymphadenomegaly, and thrombocytopenia [1, 8]. The subclinical phase can persist for months to years, with dogs appearing healthy but harboring the pathogen [8]. The chronic phase is the most severe, marked by pancytopenia, epistaxis, petechiation, and secondary infections due to bone marrow suppression [1, 8]. The hallmark hematologic abnormality is thrombocytopenia, which is present in the majority of cases [1, 15, 14].

Anaplasmosis

Granulocytic anaplasmosis (A. phagocytophilum) typically presents with acute onset of fever, lethargy, anorexia, and lameness, often with polyarthritis [11, 8]. Thrombocytopenia is a consistent finding [11]. Thrombocytotropic anaplasmosis (A. platys) is characterized by cyclic thrombocytopenia, with platelet counts fluctuating every 10-14 days [4, 8]. Clinical signs are often mild but can include petechiae, epistaxis, and prolonged bleeding [8].

Babesiosis

Canine babesiosis is primarily a hemolytic disease [15, 14]. Clinical signs range from mild lethargy and anorexia to severe, life-threatening hemolytic anemia, hemoglobinuria, icterus, and fever [1, 14]. Babesia gibsoni infections are often more severe and chronic than those caused by B. canis or B. vogeli [14]. Thrombocytopenia is also a common finding, even in the absence of anemia [14]. Hematological analysis frequently reveals regenerative anemia and thrombocytopenia [1, 15].

Diagnostic Approaches

Accurate diagnosis of canine tick-borne diseases requires a combination of clinical assessment, hematological analysis, and specific laboratory testing [13, 8]. The choice of diagnostic method depends on the stage of infection, the pathogen suspected, and the available laboratory resources.

Hematology and Clinical Pathology

Complete blood count (CBC) analysis is a critical first step. Automated impedance analyzers can detect anemia, thrombocytopenia, and leukocyte abnormalities [1, 15]. Thrombocytopenia is a common finding across all four diseases [1, 15, 14]. Serum protein electrophoresis (SPEP) and C-reactive protein (CRP) measurement can provide supportive evidence. In dogs infected with E. canis, B. canis, and H. canis, albumin levels and A/G ratios significantly decrease, while beta-2-globulin levels increase [2]. Monoclonal gammopathy patterns have been observed in E. canis and B. canis infections [2].

Microscopy

Examination of Giemsa-stained thin blood smears and buffy coat preparations can allow direct visualization of pathogens [4, 20]. Babesia organisms appear as pear-shaped or ring-shaped intraerythrocytic structures [20]. E. canis morulae may be visible within monocytes [8]. A. platys can be seen as basophilic inclusions within platelets [8]. However, microscopy has low sensitivity, particularly in chronic or low-level infections, and requires significant expertise [4, 13].

Molecular Diagnostics

Polymerase chain reaction (PCR) is considered the gold standard for the detection of active infection [4, 13, 15]. PCR assays target specific genetic sequences, such as the 16S rRNA gene for bacteria and the 18S rRNA gene for protozoa [13, 11]. Real-time PCR (qPCR) using SYBR Green or probe-based chemistry allows for quantification of pathogen DNA and can be multiplexed to detect multiple pathogens simultaneously [13]. Duplex real-time PCR assays have been developed for the simultaneous detection of B. vogeli and E. canis, and B. gibsoni and H. canis, demonstrating high sensitivity and specificity [13]. PCR is particularly useful for detecting co-infections and for confirming cases where serology is equivocal [4, 3].

Serology

Serological tests detect antibodies against specific pathogens. Commercial ELISA kits are widely used for the detection of antibodies to B. burgdorferi, E. canis, and Anaplasma spp. [6, 32]. Indirect immunofluorescence assay (IFA) is another common method for detecting antibodies to Babesia and Ehrlichia species [31]. Serology indicates exposure to the pathogen but cannot distinguish between active and past infection [6]. Seroprevalence studies provide valuable epidemiological data [6, 31, 32].

flowchart TD
    A[Clinical Suspicion of Canine Tick-Borne Disease], > B{Complete Blood Count & Blood Smear}
    B, > C[Thrombocytopenia, Anemia, or Visible Pathogens]
    C, > D[PCR Panel for Tick-Borne Pathogens]
    D, > E{Pathogen DNA Detected?}
    E, >|Yes| F[Confirm Active Infection]
    E, >|No| G[Serology Panel]
    G, > H{Antibodies Detected?}
    H, >|Yes| I[Consider Past Exposure or Early Infection]
    H, >|No| J[Re-evaluate Clinical Signs & Consider Other Etiologies]
    F, > K[Initiate Targeted Therapy]
    I, > K
    K, > L[Monitor Clinical Response & Repeat CBC]

Treatment and Management

Therapeutic strategies for canine tick-borne diseases are directed at eliminating the pathogen and providing supportive care [8, 34]. Antimicrobial resistance is a growing concern, and treatment should be guided by the specific pathogen and clinical presentation [14].

Lyme Disease

Doxycycline is the antibiotic of choice for canine Lyme disease, typically administered at 10 mg/kg orally every 24 hours for 30 days [8]. Clinical improvement is usually rapid, with resolution of lameness within 24-48 hours [8]. Supportive care includes fluid therapy for renal involvement [8].

Ehrlichiosis

Doxycycline is also the first-line treatment for ehrlichiosis, administered at 5-10 mg/kg orally every 12-24 hours for 28 days [8]. In severe chronic cases with pancytopenia, supportive care including blood transfusions and immunosuppressive doses of corticosteroids may be necessary [8]. Response to therapy is monitored by resolution of thrombocytopenia and clinical signs [1].

Anaplasmosis

Doxycycline is effective against both A. phagocytophilum and A. platys [8]. The recommended dosage is 10 mg/kg orally every 24 hours for 14-28 days [8]. Clinical signs typically resolve within 24-48 hours of initiating therapy [8].

Babesiosis

Treatment of babesiosis involves the use of antiprotozoal drugs. Imidocarb dipropionate is effective against B. canis and B. vogeli, administered at 5-6.6 mg/kg intramuscularly or subcutaneously, repeated once after 14 days [8]. For B. gibsoni, a combination of atovaquone (13.3 mg/kg orally every 8 hours) and azithromycin (10 mg/kg orally every 24 hours) for 10 days is recommended [8, 14]. Supportive care includes intravenous fluids, blood transfusions for severe anemia, and management of complications such as disseminated intravascular coagulation [8].

Prevention and Control

Prevention of canine tick-borne diseases relies on effective tick control and, for Lyme disease, vaccination [21, 8, 34].

Tick Control

The cornerstone of prevention is the consistent use of acaricidal products [21, 34]. Topical formulations, collars, and oral isoxazoline drugs are available [21]. A field trial in Cambodia demonstrated that a long-acting imidacloprid/flumethrin collar provided superior protection against tick-borne pathogens compared to monthly topical fipronil [21]. The speed of kill is critical for blocking pathogen transmission [21]. Owners should be educated on the importance of year-round tick prevention, even in regions with seasonal tick activity [34].

Vaccination

Vaccines against B. burgdorferi are available for dogs [8]. These vaccines target outer surface proteins (OspA or OspC) and induce an antibody response that kills spirochetes in the tick midgut or blocks transmission [8]. Vaccination is recommended for dogs living in or traveling to endemic areas [8]. No commercial vaccines are currently available for ehrlichiosis, anaplasmosis, or babesiosis.

Environmental Management

Reducing tick habitat around the home, such as keeping grass short and removing leaf litter, can decrease tick exposure [8]. Regular inspection of dogs for ticks, especially after walks in wooded or grassy areas, is recommended [8].

Conclusion

Canine tick-borne diseases, including Lyme disease, ehrlichiosis, anaplasmosis, and babesiosis, are complex, globally distributed infections that pose significant diagnostic and therapeutic challenges. The term "dog tick transmitted diseases" encompasses a diverse group of pathogens with distinct biological mechanisms, yet they share common clinical features such as thrombocytopenia and fever. Advances in molecular diagnostics, particularly real-time PCR, have greatly improved the ability to detect and differentiate these pathogens, including common co-infections. Effective management requires a combination of accurate diagnosis, targeted antimicrobial therapy, and rigorous tick prevention. Ongoing surveillance and research are essential to monitor the changing epidemiology of these diseases and to develop improved control strategies.

References

[1] Siriporn, B., & Juasook, A. (2022). Clinical and hematological changes of canine tick-borne diseases in Thailand. Comparative Clinical Pathology. https://www.semanticscholar.org/paper/15dbef58387bef2dcaedf8320739ad2c7c9e43a3

[2] Asawakarn, S., & Taweethavonsawat, P. (2021). Characterization of serum protein electrophoresis patterns and C-reactive protein in canine tick-borne diseases. Veterinary World. https://www.semanticscholar.org/paper/b8f9e2d7b946eb97d05881e6b616ebec4f0a05c2

[3] Andersson, M. O., Tolf, C., Tamba, P., et al. (2017). Canine tick-borne diseases in pet dogs from Romania. Parasites & Vectors. https://www.semanticscholar.org/paper/23d65b8a7fe88f980d299ba9701c3d707bff3978

[4] Abd Rani, P. A. M., Irwin, P., Coleman, G., et al. (2011). A survey of canine tick-borne diseases in India. Parasites & Vectors. https://www.semanticscholar.org/paper/3eade7f17fcc664b3ad1cfaef7db8401aff0119a

[5] Yousaf, A., Rehman, A., Abbas, T., et al. (2023). Tick-borne diseases of Canine and Feline in Pakistan. Trends in Animal and Poultry Sciences. https://www.semanticscholar.org/paper/cb603ca912302bab7407e69a5f1d4c66a550513b

[6] Mendoza-Roldan, J., Benelli, G., Bezerra-Santos, M., et al. (2021). Seropositivity to canine tick-borne pathogens in a population of sick dogs in Italy. Parasites & Vectors. https://www.semanticscholar.org/paper/2dea76805a409868b1be3ca12f04a38b34c90301

[7] Sormunen, J., Vesterinen, E., & Klemola, T. (2025). Ticks and Tick-Borne Pathogens Encountered by Dogs and Cats: A North European Perspective. Transboundary and Emerging Diseases. https://www.semanticscholar.org/paper/609d6ef818451a93380a43164dae99a362b7df20

[8] Lappin, M., Acvim, D., & Smith, T. (2014). CANINE TICK BORNE DISEASES. Journal. https://www.semanticscholar.org/paper/d77764f7dee08637eb529a6cb3c2e73cbb6273cb

[9] Balmori-de la Puente, A., Rodríguez-Escolar, I., Collado-Cuadrado, M., et al. (2024). Transmission risk of vector-borne bacterial diseases (Anaplasma spp. and Ehrlichia canis) in Spain and Portugal. BMC Veterinary Research. https://www.semanticscholar.org/paper/2cfc02f8fa764774abdbc58c0bf8cd2ce6d5a78f

[10] Laatamna, A., Strube, C., Bakkes, D. K., et al. (2022). Molecular detection of tick-borne pathogens in Rhipicephalus sanguineus sensu stricto collected from dogs in the steppe and high plateau regions of Algeria. Acta Tropica. https://www.semanticscholar.org/paper/9e3774f8378c22f9dc3e41c71bd55562

[11] Seo, M., Kwon, O., & Kwak, D. (2019). Molecular detection and phylogenetic analysis of canine tick-borne pathogens from Korea. Ticks and Tick-borne Diseases. https://www.semanticscholar.org/paper/ed3e39d0aaf3137d26921537da1ab590ba3ed979

[12] Radzijevskaja, J., Tamoliūnaitė, D., Sabūnas, V., et al. (2020). Prevalence and co-infection of mosquito- and tick-borne pathogens in domestic dogs suspected for canine babesiosis in Lithuania. Journal. https://www.semanticscholar.org/paper/51dfbfa9f14d747a3161cba559271edd4a0a56fe

[13] Thomas, A., Singh, H., Panwar, H., et al. (2022). Duplex real-time PCR methods for molecular detection and characterization of canine tick-borne haemoparasites from Punjab state, India. Molecular Biology Reports. https://www.semanticscholar.org/paper/7920b54c31f3a26283e3670d3fb21ae4cb7fb18f

[14] Muguiro, D. H., Nekouei, O., Lee, K. Y., et al. (2023). Prevalence of Babesia and Ehrlichia in owned dogs with suspected tick-borne infection in Hong Kong, and risk factors associated with Babesia gibsoni. Preventive Veterinary Medicine. https://www.semanticscholar.org/paper/2a69798881f9c5df56aede79f3d17eff7a26bb8c

[15] Aryal, S., Bhattarai, R. K., & Thapa, K. (2025). Comprehensive study of ticks and tick-borne diseases in dogs in Nepal: molecular identification, risk analysis and hematological alterations. BMC Veterinary Research. https://www.semanticscholar.org/paper/fba6144fa2683cc6ea349a49884166537f34cf6e

[16] Jefferies, R. (2006). Emerging canine tick-borne diseases in Australia and phylogenetic studies of the canine Piroplasmida. Journal. https://www.semanticscholar.org/paper/b30d398fe5502f64014ee2250eb42581e2d886ea

[17] Oskam, C. L., Ronai, I., & Irwin, P. (2021). The emergence of tick-borne diseases in domestic animals in Australia. Climate, Ticks and Disease. https://www.semanticscholar.org/paper/452046f40666d3254657c9c89137f66f6d700fab

[18] Attipa, C., Hicks, C., Barker, E., et al. (2017). Canine tick-borne pathogens in Cyprus and a unique canine case of multiple co-infections. Ticks and Tick-borne Diseases. https://www.semanticscholar.org/paper/593f28603fa1ac105bfe239ef36cadd685972137

[19] Elsheikha, H. (2016). Tick-borne diseases in dogs. Journal. https://www.semanticscholar.org/paper/c2e8e07053950677bd99a99c4d6c4dda42498fe5

[20] Weerathunga, D., Amarasinghe, A., Iddawela, D., et al. (2019). Prevalence of canine tick-borne haemoparasites in three Divisional Secretariat Divisions (Rambewa, Tirappane, and Galenbidunuwewa) in the Anuradhapura district, Sri Lanka. Sri Lankan Journal of Infectious Diseases. https://www.semanticscholar.org/paper/21d9b8453d8f2f039eabe4fb8a2119af2f1720b6

[21] Huggins, L., Stevenson, M., Baydoun, Z., et al. (2022). Field trial investigating the efficacy of a long-acting imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto®, Elanco) compared to monthly topical fipronil for the chemoprevention of canine tick-borne pathogens in Cambodia. Current Research in Parasitology and Vector-Borne Diseases. https://www.semanticscholar.org/paper/97c95a00e7cac796a8029236849167925431a492

[22] Soares, H., Camargo, L., Gennari, S., et al. (2014). Survey of canine tick-borne diseases in Lábrea, Brazilian Amazon: 'accidental' findings of Dirofilaria immitis infection. Revista Brasileira de Parasitologia Veterinaria. https://www.semanticscholar.org/paper/9798433cb810793b80a681f2b918767283407fd9

[23] Hii, S., Traub, R., Thompson, M., et al. (2015). Canine tick-borne pathogens and associated risk factors in dogs presenting with and without clinical signs consistent with tick-borne diseases in northern Australia. Australian Veterinary Journal. https://www.semanticscholar.org/paper/ecc3b5c9dd886a68237489fcf550a2bc2de6a5fd

[24] Ivarsson, S. (2018). Courses of disease and prevention of canine tick-borne diseases in Lithuania and Sweden. Journal. https://www.semanticscholar.org/paper/303a750d93c57abd58568cec536388962e7dc688

[25] Chen, Y.-P., & Huang, H.-P. (2003). Canine Tick-Borne Diseases: 48 Cases. Journal. https://www.semanticscholar.org/paper/731e60c8071dd7519cf257fb725fb882e5062ab4

[26] Wu, T.-J., Sun, H., Wu, Y.-C., et al. (2009). Prevalence and Risk Factors of Canine Ticks and Tick-Borne Diseases in Taipei, Taiwan. Journal. https://www.semanticscholar.org/paper/8608d214ee6b8a41f7fa682c7f9ccebca791d3f4

[27] Sioutas, G., Tsakou, K., Top, Ç., et al. (2023). First clinical case of tick-borne encephalitis (TBE) in a dog in Greece. Ticks and Tick-borne Diseases. https://www.semanticscholar.org/paper/a5749c9326acd30e3f516529967d872cca0598fe